Unknown OBSERVATIONAL NCT01276678

Multi-Analyte, Genetic, and Thrombogenic Markers of Atherosclerosis (MAGMA)

Multi-Analyte, Genetic, and Thrombogenic Markers of Atherosclerosis (The MAGMA STUDY)

Sponsor: Accumetrics, Inc.

Updated 10 times since 2017 Last updated: Nov 5, 2013 Started: Jun 30, 2010 Primary completion: Jun 30, 2014 Completion: Dec 31, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Coronary Artery Disease, this trial is ongoing. The trial is conducted by Accumetrics, Inc. and has accumulated 10 data snapshots since 2010. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

10 versions recorded

Sep 2024 — Present [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
Dec 2021 — Jul 2024 [monthly]

Unknown Status
Jan 2021 — Dec 2021 [monthly]

Unknown Status
Nov 2020 — Jan 2021 [monthly]

Unknown Status

▶ Show 5 earlier versions

Jun 2018 — Nov 2020 [monthly]

Unknown Status
May 2018 — Jun 2018 [monthly]

Unknown Status
Apr 2018 — May 2018 [monthly]

Unknown Status

Phase: NA → None
Aug 2017 — Apr 2018 [monthly]

Unknown Status NA
Jan 2017 — Aug 2017 [monthly]

Unknown Status NA

First recorded

Jun 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Accumetrics, Inc.
LifeBridge Health
Nanosphere, Inc.

Data source: LifeBridge Health

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Baltimore, United States